Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$2.3 - $4.52 $114 - $225
-50 Reduced 0.43%
11,618 $52.5 Million
Q4 2023

Jan 29, 2024

SELL
$1.93 - $3.02 $11,259 - $17,618
-5,834 Reduced 33.33%
11,668 $27.1 Million
Q4 2022

Feb 14, 2023

BUY
$3.53 - $4.5 $61,782 - $78,759
17,502 New
17,502 $63.1 Million

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $46M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Alpha Q Advisors LLC Portfolio

Follow Alpha Q Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Q Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Q Advisors LLC with notifications on news.